Delivery Order SPE2DB22D3016-SPE2DB25FBDF8
- Not listed
- The Defense Logistics Agency awarded a $12,865.02 delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 15 mg capsules (100 count) with a completion date of May 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,891.34 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100 count). The contract is firm fixed price with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a ceiling value of $1,036.54. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,109.10 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 10 mg capsules (100 count) on May 20, 2025, with completion scheduled for May 21, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100-count units) with a ceiling value of $1,276.17. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,148.12 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 30 mg capsules (100 count) with an ultimate completion date of July 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a contract value of $1,468.47. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award for pharmaceutical supplies to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100-count bottles) with a ceiling value of $1,234.72. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dexmethylphenidate ER 5 mg capsules (100-count packaging) with a ceiling value of $2,053.76. This award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed price delivery order under a competitively awarded contract with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100-count) with a ceiling value of $1,202.32. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by August 7, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDF8Delivery Order
The Defense Logistics Agency awarded a $1,419.38 delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 15 mg capsules (100-count bottles) on July 28, 2025, with completion targeted for July 29, 2025. This non-set-aside, firm fixed-price contract represents a single delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains its primary distribution operations for federal medical procurement. This delivery order falls under AmerisourceBergen's $999.999 billion IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities with an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The award demonstrates the company's continued capability to meet competitive federal procurement requirements for routine pharmaceutical deliveries supporting military operations and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/28/25 |